COVID-19 Critical Care Part II: ICU-Level Management for Non-Intensivists
Learn about our early experience with patients hospitalized with COVID-19, including recommendations for laboratory testing for prognostication and APRV ventilator mode.
COVID-19 Critical Care Part I: Airway and Ventilator Management for Non-Intensivists
View Dr. Yick's crash course in the basics of initiating mechanical ventilation.
Morning Report – Diagnosing EVALI, Exclude infection and other etiologies
This week's morning report focused on a patient presenting with constitutional symptoms and cough in the context of vape-product use, found to have hypoxemic respiratory failure with CT findings of diffuse ground glass opacities. A thorough infectious and auto-immune work…
4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease (UPLIFT)
Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke (ECASS III)
Time is tissue—and the brain is no exception. Here's the landmark article guiding our use of thombolytics within 4.5 hours of an acute stroke. Remember, the clock starts ticking from the patient's last well-known time, not from the time of…
Mild Therapeutic Hypothermia to Improve the Neurologic Outcome after Cardiac Arrest
Intensive versus Conventional Glucose Control in Critically Ill Patients (NICE-SUGAR)
This classic, often-cited article informs us that among patients in the ICU, intensive glucose control of 81-108 increased mortality as compared to a more liberal glucose target of <180. How have you applied the findings of this research to your…
Adjunctive Glucocorticoid Therapy in Patients with Septic Shock (ADRENAL)
Does hydrocortisone decrease mortality in patients with septic shock?